S E M I N A R & V I S I T I N G S P E A K E R S E R I E S

D A T E Friday, September 27th, 2019

9am

L O C A T I O N Px236/238 PsycHealth Bldg. Bannatyne Campus

S P E A K E R Tiina Kauppinen

Associate Professor, Department of Pharmacology and Therapeutics, University of Manitoba

Principal Investigator, Neuroscience Research Program, Kleysen Institute for Advanced Medicine, Health Sciences Centre

Researcher, Children’s Hospital Research Institute of Manitoba

T O P I C Microglial modulation rescues cognitive impairment caused by fetal exposure to gestational diabetes

O B J E C T I V E S

* To explain the impact of gestational diabetes exposure to offspring neurodevelopment

* To evaluate how microglial activation can influence neuronal function and viability

* To identify targets/means to modulate microglial functions

B I O

Dr. Kauppinen was born and educated in Kuopio, Finland. She obtained her M.Sc. in Biotechnology (1998) and Ph.D. in Biotechnology and Molecular Neuroscience (2001) from the University of Kuopio, Finland. She did her postdoctoral training (2002-2006) at the University of California, San Francisco, while earning a Docent degree in Neuroinflammation (2007) from University of Kuopio, Finland. She continued in the Department of Neurology, UCSF as an Adjunct Assistant Professor (2006-2012). Dr. Kauppinen joined the Faculty of Medicine, University of Manitoba in July 2012. Currently she is an associate professor in the Department of Pharmacology and Therapeutics, a principle investigator in the Neuroscience Research Program at Kleysen Institute for Advanced Medicine, Health Sciences Centre, and researcher in Children’s Hospital Research Institute of Manitoba.

Dr. Kauppinen’s research laboratory investigates how microglial functions are regulated and how to harness them to promote brain health and recovery in acute (stroke, traumatic brain injury) and chronic (Alzheimer’s disease) central nervous system disorders, brain tumour, and in neurodevelopmental disturbances (fetal exposure to gestational diabetes).

Her research is funded by grants from Alzheimer Society of Canada (ASV), Canada Foundation for Innovation (CFI), Canadian Institutes of Health Research (CIHR), Children’s Hospital Research Institute of Manitoba Foundation (CHRIM), Heart and Stroke Foundation Canada (HSFC), Manitoba Health Research Council (MHRC), Natural Sciences and Engineering Research Council of Canada (NSERC) and University of Manitoba.

Recent publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Kauppinen+Tiina+or+Tikka+Tiina+or +Tikka+T+and+minocycline https://www.ncbi.nlm.nih.gov/pubmed/?term=Kauppinen+Tiina+or+Tikka+Tiina+or+ Tikka+T+and+minocycline

For more information, contact the MNN office @ 204.235.3939

Tabrez Siddiqui Chair, MNN Seminar Series E: Tabrez.siddiqui@umanitoba.ca mailto:Tabrez.siddiqui@umanitoba.ca

Kelly Jorundson Executive Assistant Manitoba Neuroscience Network

Email: mailto:kjorund@sbrc.ca kjorund@sbrc.ca Tel: 204.235.3939 Fax: 204.237.4092

St. Boniface Hospital Albrechtsen Research Centre Room R4046 - 351 Taché Avenue, Winnipeg, MB R2H 2A6 CANADA

******************************************

http://www.manitobaneuroscience.ca/

https://www.facebook.com/manitobaneuroscience/?fref=ts https://www.instagram.com/manitobaneuroscience/ https://twitter.com/manitobaneuro